Federal Reserve Approves Alfred T. Rogers, Jr. as New President and CEO
BAFN sits 26% above its 52-week low of $4.801 on light trading volume (0.1× avg).
Summary
BayFirst Financial Corp. announced the formal appointment of Alfred T. Rogers, Jr. as its new President and CEO, with the Federal Reserve's non-objection, amidst ongoing financial challenges.
Key Events · Executive and Board Changes · BAFN
-
New CEO Appointment Formalized
Alfred T. Rogers, Jr. has been formally appointed as the Company's President, Chief Executive Officer, and a member of its Board of Directors, effective May 14, 2026.
-
Regulatory Approval Received
The appointment received the non-objection of the Federal Reserve Bank of Atlanta, completing the regulatory process for the leadership change.
-
Leadership Change Amidst Financial Distress
This executive appointment occurs as the company faces significant financial losses, regulatory capital shortfalls, and is undertaking a highly dilutive capital raise, as previously disclosed.
Analysis · BAFN · Finance
This filing formalizes the appointment of Alfred T. Rogers, Jr. as President, CEO, and a Board member, following the Federal Reserve Bank of Atlanta's non-objection. This leadership change is highly significant given the company's recent disclosures of substantial net losses, regulatory capital deficiencies, and a deeply discounted, highly dilutive capital raise. A new CEO is often brought in to navigate such critical periods and attempt a turnaround.
How filings like this one have moved
In the 30 days to Sep 12, 2026, 35.9% of the 1612 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.19%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BAFN was trading at $6.06 on NASDAQ in the Finance sector, with a market capitalization of approximately $24.9M. The 52-week trading range was $4.80 to $16.35. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.